The Neutrophil to Lymphocyte Ratio has a High Negative Predictive Value for Pathologic Complete Response in Locally Advanced Breast Cancer Patients Receiving Neoadjuvant Chemotherapy |
Eryilmaz, Melek Karakurt
(Department of Medical Oncology, Akdeniz University School of Medicine)
Mutlu, Hasan (Department of Medical Oncology, Akdeniz University School of Medicine) Salim, Derya Kivrak (Department of Medical Oncology, Akdeniz University School of Medicine) Musri, Fatma Yalcin (Department of Medical Oncology, Akdeniz University School of Medicine) Tural, Deniz (Department of Medical Oncology, Akdeniz University School of Medicine) Coskun, Hasan Senol (Department of Medical Oncology, Akdeniz University School of Medicine) |
1 | Aliustaoglu M, Bilici A, Seker M, et al (2010). The association of pre-treatment peripheral blood markers with survival in patients with pancreatic cancer. Hepatogastroenterology, 57, 640-5. |
2 | Azab B, Bhatt V, Phookhan J, et al (2012). Usefulness of the neutrophil-to-lymphocyte ratio in predicting short- and long-term mortality in breast cancer patients. Ann Surg Oncol, 19, 217-24. DOI ScienceOn |
3 | Cocquyt VF, Blondeel PN, Depypere HT, et al (2003) Different responses to preoperative chemotherapy for invasive lobular and invasive ductal breast carcinoma. Eur J Surg Oncol, 29, 361-67. DOI ScienceOn |
4 | Bear HD, Anderson S, Brown A, et al (2003). The effect on tumor response of adding sequential preoperative docetaxel to preoperative doxorubicin and cyclophosphamide:preliminary results from National Surgical Adjuvant Breast and Bowel Project Protocol B- 27. J Clin Oncol, 21, 4165-74. DOI ScienceOn |
5 | Bonadonna G, Veronesi U, Brambilla C, et al (1990). Primary chemotherapy to avoid mastectomy in tumors with diameters of three centimeters or more. J Natl Cancer Inst, 82, 1539-45. DOI |
6 | Buzdar AU, Ibrahim NK, Francis D, et al (2005). Significantly higher pathologic complete remission rate after neoadjuvant therapy with trastuzumab, paclitaxel, and epirubicin chemotherapy: results of a randomized trial in human epidermal growth factor receptor 2-positive operable breast cancer. J Clin Oncol, 23, 3676-85. DOI ScienceOn |
7 | Cortazar P, Zhang L, Untch M, et al (2014). Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis. Lancet, 13, 62422-8. |
8 | Coussens LM, Werb Z (2002). Inflammation and cancer. Nature, 420, 860-67. DOI ScienceOn |
9 | Cristofanilli M, Gonzalez-Angulo A, Sneige N, et al (2005). Invasive lobular carcinoma classic type: response to primary chemotherapy and survival outcomes. J Clin Oncol, 23, 41-8. DOI ScienceOn |
10 | Dou X, Wang RB, Yan HJ, et al (2013). Circulating lymphocytes as predictors of sensitivity to preoperative chemoradiotherapy in rectal cancer cases. Asian Pac J Cancer Prev, 14, 3881-5. 과학기술학회마을 DOI ScienceOn |
11 | Fisher B, Brown A, Mamounas E, et al (1997). Effect of preopera tive chemotherapy on local-regional disease in women with operable breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-18. J Clin Oncol, 15, 2483-93. |
12 | Fogar P, Sperti C, Basso D, et al (2006). Decreased total lymphocyte counts in pancreatic cancer: an index of adverse outcome. Pancreas, 32, 22-8. DOI ScienceOn |
13 | Fox P, Hudson M, Brown C, et al (2013). Markers of systemic inflammation predict survival in patients with advanced renal cell cancer. Br J Cancer, 109, 147-53. DOI ScienceOn |
14 | Jung MR, Park YK, Jeong O, et al (2011). Elevated preoperative neutrophil to lymphocyte ratio predicts poor survival following resection in late stagegastric cancer. J Surg Oncol, 104, 504-10. DOI ScienceOn |
15 | Kaufmann M, von Minckwitz G, Mamounas EP, et al (2012). Recommendations from an international consensus conference on the current status and future of neoadjuvant systemic therapy in primary breast cancer. Ann Surg Oncol, 19, 1508-16. DOI ScienceOn |
16 | Kaya V, Yildirim M, Demirpence O, et al (2013). Prognostic significance of basic laboratory methods in non- small-celllung cancer. Asian Pac J Cancer Prev, 14, 5473-76. 과학기술학회마을 DOI ScienceOn |
17 | Kim KI, Lee KH, Kim TR, et al (2014). Ki-67 as a predictor of response to neoadjuvant chemotherapy in breast cancer patients. J Breast Cancer, 17, 40-6. DOI ScienceOn |
18 | Lv M, Li B, Li Y, et al (2011). Predictive role of molecular subtypes in response to neoadjuvant chemotherapy in breast cancer patients in Northeast China. Asian Pac J Cancer Prev, 12, 2411-7. |
19 | Rastogi P, Anderson SJ, Bear HD, et al (2008). Preoperative chemotherapy: updates of National Surgical Adjuvant Breast and Bowel Project Protocols B-18 and B-27. J Clin Oncol, 26, 778-85. DOI ScienceOn |
20 | Noh H, Eomm M, Han A (2013). Usefulness of pretreatment neutrophil to lymphocyte ratio in predicting disease-specific survival in breast cancer patients. J Breast Cancer, 16, 55-9. DOI ScienceOn |
21 | Ownby HE, Roi LD, Isenberg RR, et al (1983). Peripheral lymphocyte and eosinophil counts as indicators of prognosis in primary breast cancer. Cancer, 52, 126-30. |
22 | Ozdemir Y, Akin ML, Sucullu I, et al (2014). Pretreatment neutrophil/lymphocyte ratio as a prognostic aid in colorectal cancer. Asian Pac J Cancer Prev, 15, 2647-50. 과학기술학회마을 DOI ScienceOn |
23 | Ray-Coquard I, Cropet C, Van Glabbeke M, et al (2009). European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group. Lymphopenia as a prognostic factor for overall survival in advanced carcinomas, sarcomas, and lymphomas. Cancer Res, 69, 5383-91. DOI ScienceOn |
24 | Schmidt H, Suciu S, Punt CJ, et al (2007). Pretreatment levels of peripheral neutrophils and leukocytes as independent predictors of overall survival in patients with American Joint Committee on Cancer Stage IV Melanoma: results of the EORTC 18951 Biochemotherapy Trial. J Clin Oncol, 25, 1562-69. DOI ScienceOn |
25 | Sinacki M, Badzio A, Welnicka-Jaskiewicz M, et al (2011). Pattern of care in locally advanced breast cancer: focus on local therapy. Breast, 20, 145-50. DOI ScienceOn |
26 | Strieter RM, Burdick MD, Mestas J, et al (2006). Cancer CXC chemokine networks and tumour angiogenesis. Eur J Cancer, 42, 768-78. DOI ScienceOn |
27 | Templeton AJ, Ace O, McNamara MG, et al (2014). Prognostic role of platelet to lymphocyte ratio in solid tumors: a systematic review and meta-analysis. Cancer Epidemiol Biomarkers Prev, 23, 1204-12. DOI ScienceOn |
28 | Unal D, Eroglu C, Kurtul N, et al (2013). Are neutrophil/lymphocyte and platelet/lymphocyte rates in patients with non-small cell lung cancer associated with treatment response and prognosis? Asian Pac J Cancer Prev, 14, 5237-42. 과학기술학회마을 DOI ScienceOn |
29 | Colleoni M, Viale G, Zahrieh D, et al (2004). Chemotherapy is more effective in patients with breast cancer not expressing steroid hormone receptors: a study of preoperative treatment. Clin Cancer Res, 10, 6622-8. DOI ScienceOn |
30 | Hennessy BT, Hortobagyi GN, Rouzier R, et al (2005). Outcome after pathologic complete eradication of cytologically proven breast cancer axillary node metastases following primary chemotherapy. J Clin Oncol, 23, 9304-11. DOI ScienceOn |
![]() |